Literature DB >> 11229417

NK1 receptor antagonists--are they really without effect in the pain clinic?

L A Urban, A J Fox.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11229417     DOI： 10.1016/s0165-6147(00)01578-9

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN： 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  14 in total

1.  Characterization of RO4583298 as a novel potent, dual antagonist with in vivo activity at tachykinin NK₁ and NK₃ receptors.

Authors:  P Malherbe; F Knoflach; M C Hernandez; T Hoffmann; P Schnider; R H Porter; J G Wettstein; T M Ballard; W Spooren; L Steward
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

Review 2.  Neuropeptide receptors as potential drug targets in the treatment of inflammatory conditions.

Authors:  Erika Pintér; Gábor Pozsgai; Zsófia Hajna; Zsuzsanna Helyes; János Szolcsányi
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

3.  Development of a spontaneously active dorsal root ganglia assay using multiwell multielectrode arrays.

Authors:  Kim Newberry; Shuya Wang; Nina Hoque; Laszlo Kiss; Michael K Ahlijanian; James Herrington; John D Graef
Journal:  J Neurophysiol       Date:  2016-04-06       Impact factor: 2.714

4.  Spinal neurons that possess the substance P receptor are required for the development of central sensitization.

Authors:  Sergey G Khasabov; Scott D Rogers; Joseph R Ghilardi; Christopher M Peters; Patrick W Mantyh; Donald A Simone
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

Review 5.  Predictive validity of behavioural animal models for chronic pain.

Authors:  Odd-Geir Berge
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

6.  An antinociceptive role for substance P in acid-induced chronic muscle pain.

Authors:  Chia-Ching John Lin; Wei-Nan Chen; Chien-Ju Chen; Yi-Wen Lin; Andreas Zimmer; Chih-Cheng Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

Review 7.  Neuropeptides and their receptors: innovative science providing novel therapeutic targets.

Authors:  Susan D Brain; Helen M Cox
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

8.  Effects of neurokinin-1 receptor agonism and antagonism in the rostral ventromedial medulla of rats with acute or persistent inflammatory nociception.

Authors:  M V Hamity; S R White; D L Hammond
Journal:  Neuroscience       Date:  2009-11-03       Impact factor: 3.590

9.  Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice.

Authors:  Glenn W Stevenson; Jim Cormier; Hannah Mercer; Chloe Adams; Catherine Dunbar; S Stevens Negus; Edward J Bilsky
Journal:  Life Sci       Date:  2009-06-24       Impact factor: 5.037

10.  cAMP signaling through protein kinase A and Epac2 induces substance P release in the rat spinal cord.

Authors:  Wenling Chen; James A McRoberts; Helena S Ennes; Juan Carlos Marvizon
Journal:  Neuropharmacology       Date:  2021-03-17       Impact factor: 5.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.